Rheumatoid Arthritis


Rheumatoid Arthritis (RA) is one of the most common autoimmune diseases, affecting more than 21 million people worldwide. It is a systemic autoimmune disease that affects people of all ages and can have a major impact on quality of life. It is characterized by chronic inflammation (mainly of the joints), pain and fatigue. In 30–40 percent of cases, conventional drugs are ineffective or poorly tolerated. Now, our biopharmaceuticals are paving the way for a new treatment that can impede progression of the disease and prevent joint damage and pain.

Safety Update Information for Healthcare Professionals
I understand the following:
The information contained in this Letter is for the sole purpose of use and knowledge of Healthcare Professionals (HCPs) Only. 
If any Individual other than HCPs access the information contained in this Letter and act thereon, then Roche will not be liable for any consequences in relation thereto.
Patients and their relatives should not access the information contained in this Letter. They are advised to consult their treating physicians.